Found 21 matching trials
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
PHASE4The purpose of this study is to evaluate the efficacy and safety of Empagli...
Location
Kyung Hee University Hospital at Gangdong
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
PHASE3The purpose of this study is to assess safety and efficacy of empagliflozin...
Location
Multiple Locations
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)
N/AGIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Cognitive Protective Effect of Newer Antidiabetic Drugs
N/AThe proposed study aims to:
1. Explore the cognitive protective effects of...
Location
Alexandria University
Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus
PHASE3The goal of this clinical trial is to compare the effects of Sitagliptin an...
Location
The University of Lahore
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
PHASE4The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Location
BIRDEM General Hospital
Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus
PHASE1This study is a multicenter, randomized, controlled study. A sample size of...
Location
The Second Affiliated Hospital, Guangzhou Medical University
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
N/ATo perform an observational analysis to emulate a target trial (i.e., a hyp...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio
N/AA blood glucose level of equal to or greater than 180 mg/dL that occurred d...
Location
College of Medicine, University of Diyala
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
PHASE3This study will investigate the efficacy and long term safety and tolerabil...
Location
1245.31.10145 Boehringer Ingelheim Investigational Site